BioNTech will receive an upfront payment of $185 million, including an equity investment of approximately $113 million, and be eligible to receive future milestone payments of up to $563 million for a potential total consideration of $748 million...
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”